Depression Clinical Trial
Official title:
Our Family Our Future: Family Prevention of HIV Risk and Depression in HIV-endemic South Africa
Verified date | July 2017 |
Source | Brown University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to assess the feasibility and acceptability of a family-based preventive intervention designed to reduce sexual risk behaviors and depressive symptoms among South African adolescents and their parents/guardians/caregivers.
Status | Completed |
Enrollment | 152 |
Est. completion date | July 31, 2017 |
Est. primary completion date | July 31, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: PARENTS/GUARDIANS/CAREGIVERS 1. 18+ years 2. primary caregiver or the person responsible for childcare in the household on a day to day basis (as identified by the household); 3. when more than one primary caregiver exists in the household, one will be chosen at random; 4. lives in the household at least 4 days a week 5. sub clinical thresholds of depressive symptoms Adolescent inclusion criteria are: 1. 13-15 years; 2. concurs that the adult identified is their primary caregiver; 3. when more than one child in the family falls within the eligible age range, one child will be chosen at random; 4. lives in the household at least 4 days a week; 5. sub clinical thresholds of depressive symptoms Exclusion Criteria: PARENTS/GUARDIANS/CAREGIVERS & Adolescents 1. cognitive impairments that would not allow them to provide informed consent or assent; 2. if they participated in qualitative phases of the study 3. report no or low symptoms or clinically significant thresholds of depression - |
Country | Name | City | State |
---|---|---|---|
South Africa | Caroline Kuo | Cape Town | Western Cape |
Lead Sponsor | Collaborator |
---|---|
Brown University | University of Cape Town |
South Africa,
Kuo C, Atujuna M, Mathews C, Stein DJ, Hoare J, Beardslee W, Operario D, Cluver L, K Brown L. Developing family interventions for adolescent HIV prevention in South Africa. AIDS Care. 2016;28 Suppl 1:106-10. doi: 10.1080/09540121.2016.1146396. Epub 2016 F — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in sexual behavior or intended sexual behavior at 4 months post-intervention | as measured through lifetime and past 3 month sexual acts, condom use, HIV and STI status, prior pregnancy | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | |
Primary | Change or maintenance of depressive symptoms at sub-clinical range from baseline to 4 months post-intervention measured by CES-D and CES-DC | Self-reported depressive symptoms | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | |
Primary | Intervention acceptability - satisfaction with intervention content, delivery, length using the client satisfaction questionnaire and as measured on a likert scale response and as open-ended response options | acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks | ||
Primary | Intervention feasibility measured by attendance, retention for outcome assessments, fidelity | cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks | ||
Secondary | Change in resilience from baseline to 4 months post-intervention as measured through CD-RISC | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in depression impairment from baseline to 4 months post-intervention as measured through DISP and CPODMV | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in perceived HIV risk susceptibility from baseline to 4 months post-intervention using a ranking derived from a 0-100 and as measured on a likert scale response | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in HIV knowledge from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in HIV stigma from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in norms and attitudes about sex from baseline to 4 months post-intervention as measured on a likert scale response | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in norms and attitudes about condoms from baseline to 4 months post-intervention as measured through the condom attitudes scale and likert response questions | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in sexual behavior self-efficacy from baseline to 4 months post-interventionusing a ranking derived from a 0-100 and as measured on a likert scale response | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in anxiety from baseline to 4 months post-interventionas measured through BAI and RCMAS | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in psychological distress from baseline to 4 months post-intervention as measured through K6 and SDQ | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in trauma symptoms from baseline to 4 months post-intervention as measured through PCL and NSESSS | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in substance use from baseline to 4 months post-intervention as measured through AUDIT and DUDIT | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in hope from baseline to 4 months post-intervention as measured through BHS | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in social support from baseline to 4 months post-intervention as measured through MSPSS | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in family relationship from baseline to 4 months post-intervention as measured through Family Relationship Scale | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Communication Scale | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Sex Communication Scale | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in family relationship from baseline to 4 months post-intervention as measured through the Inventory of Parent-peer Attachment | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in parenting from baseline to 4 months post-interventionas measured through the Parental Monitoring Questionnaire | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention | ||
Secondary | Change in parenting from baseline to 4 months post-intervention as measured through the Parenting Scale | assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |